UroGen Pharma (URGN) Return on Invested Capital [ROIC] (2022 - 2026)
UroGen Pharma (URGN) reported Return on Invested Capital [ROIC] of -109.09% for Q2 2026, up 126.77 percentage points from -235.85% a year earlier and up 145.10 percentage points from the prior quarter.
UroGen Pharma (URGN) Return on Invested Capital [ROIC] (2022 - 2026) Analysis & Trends
For FY2025, UroGen Pharma posted Return on Invested Capital [ROIC] of -192.59%, down 60.26 percentage points from FY2024.
- Return on Invested Capital [ROIC] has a three-year change of +760.34 percentage points (FY2022 to FY2025).
- By year, Return on Invested Capital [ROIC] came in at -132.33% in FY2024 (+183.39 pp), -315.72% in FY2023 (+637.21 pp) and -952.93% in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Return on Invested Capital [ROIC] since Q4 2024.
- Year over year, Return on Invested Capital [ROIC] gained in four of the last eight quarters, with an average year-over-year change of -114.99 percentage points.
- The high point for year-over-year Return on Invested Capital [ROIC] in five years was Q3 2024 (a gain of 808.27 percentage points); the low point was Q4 2025 (a drop of 991.03 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -254.19% (Q1 2026), -1065.43% (Q4 2025) and -744.56% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | UroGen Pharma | 2.02 Bn | 1.53 Bn | 65.88 Mn | -109.09% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -109.09% |
| Mar 31, 2026 | -254.19% |
| Dec 31, 2025 | -1,065.43% |
| Sep 30, 2025 | -744.56% |
| Jun 30, 2025 | -235.85% |
| Mar 31, 2025 | -114.49% |
| Dec 31, 2024 | -74.40% |
| Sep 30, 2024 | -60.82% |
| Jun 30, 2024 | -85.88% |
| Mar 31, 2024 | -152.50% |
| Dec 31, 2023 | -145.86% |
| Sep 30, 2023 | -869.09% |
| Dec 31, 2022 | -943.21% |
| Sep 30, 2022 | -404.84% |
| Jun 30, 2022 | -200.05% |
| Mar 31, 2022 | -283.68% |
UroGen Pharma Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=URGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();